Immunoradiometric assay for the N-terminal fragment of proatrial natriuretic peptide in human plasma

Yoshito Numata, Keiji Dohi, Ayako Furukawa, Shino Kikuoka, Hidehisa Asada, Takahiro Fukunaga, Yasushi Taniguchi, Kazuyuki Sasakura, Tetsuo Tsuji, Ken Inouye, Michihiro Yoshimura, Hiroshi Itoh, Masashi Mukoyama, Hirofumi Yasue, Kazuwa Nakao

研究成果: Article査読

28 被引用数 (Scopus)

抄録

Recently, the N-terminal fragment of proatrial natriuretic peptide (N- terminal proANP) has been proposed as a marker of chronic congestive heart failure. In this study, we established a two-step immunoradiometric assay using monoclonal antibodies and synthetic N-terminal proANP (1-67) as a standard. It allows us to measure plasma N-terminal proANP in only 4 h without prior extraction. The detection limit of this assay was 15 pmol/L for a 100 μL sample of plasma. Within-run CVs ranged from 1.7% to 2.9% and between-run CVs ranged from 4.2% to 5.1%. The dilution curves of plasma samples showed good linearity and analytical recovery was 89-104%. The mean (±SD) N-terminal proANP in plasma of 33 healthy subjects was 188 (±71) pmol/L and 1030 (±411) pmol/L in 25 patients with heart failure. Our immunoradiometric assay is rapid and precise enough for routine determination of N-terminal proANP in human plasma.

本文言語English
ページ(範囲)1008-1013
ページ数6
ジャーナルClinical Chemistry
44
5
DOI
出版ステータスPublished - 1998
外部発表はい

ASJC Scopus subject areas

  • 臨床生化学
  • 生化学、医学

フィンガープリント

「Immunoradiometric assay for the N-terminal fragment of proatrial natriuretic peptide in human plasma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル